Literature DB >> 11277621

Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.

D Pappagianis1.   

Abstract

The studies reported in this review indicate that, whereas the expectations from the molecular approach help to excite and enlighten us, the realities suggest that even some less modern approaches may provide the necessary practical solutions to problems of serology and vaccination against coccidioidomycosis. Concurrent conduct of the two approaches should maximize the chances for success. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277621     DOI: 10.1006/fgbi.2000.1243

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  12 in total

Review 1.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

2.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

Review 3.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

Review 4.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells.

Authors:  Lance Nesbit; Suzanne M Johnson; Demosthenes Pappagianis; Neil M Ampel
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

6.  A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.

Authors:  Nelson Delgado; Jianmin Xue; Jieh-Juen Yu; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.

Authors:  Jianmin Xue; Xia Chen; Dale Selby; Chiung-Yu Hung; Jieh-Juen Yu; Garry T Cole
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

8.  Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.

Authors:  Tao Peng; Lisa Shubitz; Julie Simons; Robert Perrill; Kris I Orsborn; John N Galgiani
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

Authors:  Chiung-Yu Hung; Brady J Hurtgen; Michael Bellecourt; Sam D Sanderson; Edward L Morgan; Garry T Cole
Journal:  Vaccine       Date:  2012-05-08       Impact factor: 3.641

10.  Coccidioidomycosis among workers at an archeological site, northeastern Utah.

Authors:  Lyle R Petersen; Stacie L Marshall; Christine Barton-Dickson; Rana A Hajjeh; Mark D Lindsley; David W Warnock; Anil A Panackal; Joseph B Shaffer; Maryam B Haddad; Frederick S Fisher; David T Dennis; Juliette Morgan
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.